UAB doses world's first patient in investigational gene therapy trial for BAG3-associated dilated cardiomyopathy
September 24, 2026
September 24, 2026
BIRMINGHAM, Alabama, Sept. 24 -- The University of Alabama issued the following news:
* * *
UAB doses world's first patient in investigational gene therapy trial for BAG3-associated dilated cardiomyopathy
*
Pankaja Arora, M.D., and Garima Arora, M.D., with members of the Cardiovascular Clinical and Translational Research ProgramThe University of Alabama at Birmingham has made history by dosing the first patient in the world in a first-in-h . . .
* * *
UAB doses world's first patient in investigational gene therapy trial for BAG3-associated dilated cardiomyopathy
*
Pankaja Arora, M.D., and Garima Arora, M.D., with members of the Cardiovascular Clinical and Translational Research ProgramThe University of Alabama at Birmingham has made history by dosing the first patient in the world in a first-in-h . . .